Medtronic MDT recently announced two ... slim X2 became the first AID system to integrate with Abbott’s new FreeStyle Libre 2 Plus sensor. The breakthrough development enables t:slim X2 users ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Medtronic (NYSE:MDT) today announced new, long-term study data further supporting its Symplicity Spyral renal denervation ...

which is part of the Medtronic Cardiovascular Portfolio. "The potential of Affera is limitless. We will continue to fulfill our commitment to innovation, including new indications, to advance ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Medtronic also announced a partnership with Siemens Healthineers to explore opportunities to further expand access to advanced pre- and post-operative imaging technologies for spine care. New ...

New features, especially with regard to lead design and geometry, characterize the system. Specifically Medtronic redesigned ... of reed-switch to a Hall sensor. Furthermore, it has developed ...

DexCom's Q3 results showed disappointing 2% revenue growth and a 26% decline in operating income. Click here to read my DXCM ...

Users were told to contact Medtronic if they experience significantly reduced battery life to determine whether replacement is necessary. The new alert updates a previous one issued in July.

Shares of NYSE:MDT opened at $90.01 on Monday. Medtronic has a 12 month low of $68.84 and a 12 month high of $91.49. The business has a 50-day moving average of $87.74 and a two-hundred day moving ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...